Profound increases private placement to $6.45M (U.S.)

Executive Summary

• Profound Medical Corp. has upsized its private placement offering to raise gross proceeds of up to $6.45 million (U.S.).
• The offering involves the issuance of up to 921,428 common shares at a price of $7.00 (U.S.) per share.
• The increase in size is to accommodate participation by a long-term existing investor, with closing expected on or prior to December 30, 2025.

Key Details

• Gross Proceeds: Up to $6.45 million (U.S.).
• Share Price: $7.00 (U.S.) per common share.
• Quantity of Shares: Up to 921,428 common shares.
• Hold Period: Four months plus one day from the closing date of the offering.
• Closing Date: Expected on or prior to December 30, 2025.
• Use of Proceeds: Expansion of sales and marketing, working capital, research and development, strategic transactions, and general corporate purposes.
• Previous Announcement: The private placement was previously announced on December 19, 2025.

Notable Quotes

• None provided in the text.